The Valley Desk

NCT06040099 · Interventional trial

A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE

Overall registry status Active not recruiting

Phase 2

Conditions Hepatocellular Carcinoma (HCC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov